IL-17 signaling in host defense against Candida albicans.
about
The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findingsElucidating the immunological function of the Cryptococcus neoformans capsuleCrystal structures of interleukin 17A and its complex with IL-17 receptor AT cell-mediated host immune defenses in the lungSkin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses.Effect of Delta-9-tetrahydrocannabinol on mouse resistance to systemic Candida albicans infection.The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor κB family proteins.Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells.Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway.CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans.Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitroT helper cell subsets specific for Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosisInsights from human studies into the host defense against candidiasis.Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell PathogenicityInterleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis.Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.Microbial-induced Th17: superhero or supervillain?Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis.Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome.Th17 cells in immunity to Candida albicans.TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?Unexpected targets and triggers of autoimmunity.Immunoresponses in dermatomycoses.Beyond passive immunization: toward a nanoparticle-based IL-17 vaccine as first in class of future immune treatments.Harnessing the Therapeutic Potential of Th17 Cells.Infections from 7 Clinical Trials of Ixekizumab, an Anti-Interleukin-17A Monoclonal Antibody, in Patients with Moderate-to-Severe Psoriasis.Activation of murine invariant NKT cells promotes susceptibility to candidiasis by IL-10 induced modulation of phagocyte antifungal activity.A Review of the Use of Secukinumab for Psoriatic Arthritis.Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study.Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3).Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE).Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE).Candida Immunity
P2860
Q24623195-2C43D022-E539-422A-9BF3-6EABBDE84648Q26859234-BC81C8E0-9B3C-492C-B679-3F258C08B016Q27684681-0CE48969-FD5F-451A-8AC7-DEDEF50630BFQ28395374-684D06CD-918D-41CB-8859-A283330CF200Q33709446-2AA61643-4F1C-4674-A577-F8A3B08703AEQ33946093-6807AF74-1D97-49AA-BE79-0295B478F6E9Q33954291-3D37C264-AB44-45A1-9BF4-849BBD283DB3Q34350869-E0BEFB4E-C16A-4471-AB05-4835A23BAB87Q34405961-40A46CCB-7574-4DAF-A5DF-532852A2854EQ35098244-4F858770-2741-43A9-A227-CDA34B92D997Q35108316-DF8D1336-25DA-45C7-9AE8-5E7EF4F750D4Q35108903-DBA6670F-FE8F-43F7-8D5A-8C713B530FFAQ35722365-7D580FE5-9E87-4EBC-BA35-E74EB294B998Q36080619-49BBFDBE-9FA6-4B62-AC46-787CCC31F884Q36352360-86824A85-E4A4-4BDD-845F-9FFDA6B2C2DAQ36379309-8D6A9AE2-8BA4-4A41-A016-CCA6619A411FQ36511529-D77DA460-6D60-4294-B668-4B7ED26AD80CQ36839871-8F343787-F25C-47F5-9DA0-154AD62827CAQ37624083-21DC5E09-DC0F-473E-AB54-DD0FB0E00923Q37974985-77821373-7D39-4582-B0A0-B1F3875E64F5Q38011298-6CCA55F5-29CD-4D5E-8F94-370BFEC93F5EQ38016854-429BABE3-6A92-4495-A67D-4E6E9EE0381EQ38208785-65F195D7-6A55-4006-84E0-489E1021F342Q38367351-8B26953F-1622-45D2-8037-018842383647Q38467270-D3ABDB16-DA53-4BCC-A006-93DD8AAF2C90Q38535119-DE2AF034-D63C-4681-A561-DC0ED9560E2AQ38732809-FD7EBC86-8BDD-4F95-BAA6-B3A8373CFFD5Q40685338-49E4BD4C-FE53-4224-B7D5-72AD535F14A7Q47160133-AEA98FC6-3E29-42DD-A6D8-3268D0AEC4D1Q52650418-66D25076-FAA1-400F-A331-CBAFD616EEB5Q52653700-6BA69895-E4D7-49B3-B935-41CFFE8C92F6Q53438409-C8B23C6B-D61D-4320-831B-8E605E970CEFQ53471047-CFC58397-4548-4A4B-BAEE-601F7825896CQ59072636-21130484-2323-4234-91E8-F8C9672B93D1
P2860
IL-17 signaling in host defense against Candida albicans.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
IL-17 signaling in host defense against Candida albicans.
@ast
IL-17 signaling in host defense against Candida albicans.
@en
type
label
IL-17 signaling in host defense against Candida albicans.
@ast
IL-17 signaling in host defense against Candida albicans.
@en
prefLabel
IL-17 signaling in host defense against Candida albicans.
@ast
IL-17 signaling in host defense against Candida albicans.
@en
P2093
P2860
P1433
P1476
IL-17 signaling in host defense against Candida albicans.
@en
P2093
Alanna C Peterson
Nydiaris Hernández-Santos
Sarah L Gaffen
P2860
P2888
P304
P356
10.1007/S12026-011-8226-X
P577
2011-08-01T00:00:00Z